Medication Response Reference: From Drug Response to Mechanism Identification

1 Chapter Abstract

Every drug response — therapeutic benefit, null response, side effect at a specific dose — is diagnostic information. This chapter provides: (a) generic frameworks for reading dose-response curves, side-effect patterns, and cross-drug combination signals; (b) per-medication clinical entries with response/non-response interpretation, dose-dependent differential diagnosis, and combination inference; and (c) a consolidated per-drug dose-range reference with cross-drug predictive patterns. For each drug, the central question is: what does the response reveal about which mechanism is broken?

Chapter Roadmap: How to Use This Chapter

For patients: use the medication index and the per-drug entries to understand what a benefit, null response, or side effect at a specific dose means for you; the response-nonresponse interpretation is written to be readable without medical training. This is an interpretive reference, not a prescribing guide — route any dose or combination decision through your clinician.

For caregivers: use the per-drug entries to track and report the patient’s response pattern to the clinical team; the dose-response categories (Dose-Response Curve Shape as Diagnostic Readout) explain why low doses behave differently.

For clinicians: read the generic frameworks first — dose-response categories (Dose-Response Curve Shape as Diagnostic Readout), side-effects-as-diagnostic-probes (Side Effects as Diagnostic Probes), and the null-ladder (null ladder algorithm) — then the per-system drug sections for mechanism interpretation.

For researchers: read the synthesis algorithm (Differential Diagnostic Algorithm - From Drug Responses to Bottleneck Localization), pharmacodiagnostic matrix (Pharmacodiagnostic Matrix - Constraint-Satisfaction Inference), null-subtyping (Null Subtyping - Absent vs. Blocked vs. Overwhelmed vs. Biased), and origin-elimination (What Pharmacodiagnostics Can and Cannot Rule Out: Origin Hypotheses) sections as the formal frameworks for drug-response-driven mechanism identification.

1 Chapter Abstract

2 Contents